310 related articles for article (PubMed ID: 15949329)
1. [Construction of glucosylceramide synthase-specific siRNA expression vector and its efficiency in reversal of drug resistance in breast carcinoma cells].
Sun YL; Zhou GY; Li KN; Li WT; Song XR; Gao P
Zhonghua Yi Xue Za Zhi; 2005 Mar; 85(8):518-21. PubMed ID: 15949329
[TBL] [Abstract][Full Text] [Related]
2. Reversal of MDR1 gene-dependent multidrug resistance using short hairpin RNA expression vectors.
Gan HZ; Zhang GZ; Zhao JS; Zhang FC; Bu LS; Yang SJ; Piao SL; Du ZW; Gao S; Zheng DM
Chin Med J (Engl); 2005 Jun; 118(11):893-902. PubMed ID: 15978189
[TBL] [Abstract][Full Text] [Related]
3. Glucosylceramide synthase blockade down-regulates P-glycoprotein and resensitizes multidrug-resistant breast cancer cells to anticancer drugs.
Gouazé V; Liu YY; Prickett CS; Yu JY; Giuliano AE; Cabot MC
Cancer Res; 2005 May; 65(9):3861-7. PubMed ID: 15867385
[TBL] [Abstract][Full Text] [Related]
4. [Inhibition of ovarian cancer growth by small interfering RNA targeting X-linked inhibitor of apoptosis gene].
Ma JJ; Chen BL; Xin XY
Zhonghua Fu Chan Ke Za Zhi; 2007 Feb; 42(2):124-8. PubMed ID: 17442189
[TBL] [Abstract][Full Text] [Related]
5. Tumor-specific RNAi targeting eIF4E suppresses tumor growth, induces apoptosis and enhances cisplatin cytotoxicity in human breast carcinoma cells.
Dong K; Wang R; Wang X; Lin F; Shen JJ; Gao P; Zhang HZ
Breast Cancer Res Treat; 2009 Feb; 113(3):443-56. PubMed ID: 18327707
[TBL] [Abstract][Full Text] [Related]
6. Transfer of siRNA against XIAP induces apoptosis and reduces tumor cells growth potential in human breast cancer in vitro and in vivo.
Zhang Y; Wang Y; Gao W; Zhang R; Han X; Jia M; Guan W
Breast Cancer Res Treat; 2006 Apr; 96(3):267-77. PubMed ID: 16341821
[TBL] [Abstract][Full Text] [Related]
7. MDR1 (multidrug resistence 1) can regulate GCS (glucosylceramide synthase) in breast cancer cells.
Zhang X; Wu X; Li J; Sun Y; Gao P; Zhang C; Zhang H; Zhou G
J Surg Oncol; 2011 Oct; 104(5):466-71. PubMed ID: 21538359
[TBL] [Abstract][Full Text] [Related]
8. Ceramide reduction and transcriptional up-regulation of glucosylceramide synthase through doxorubicin-activated Sp1 in drug-resistant HL-60/ADR cells.
Uchida Y; Itoh M; Taguchi Y; Yamaoka S; Umehara H; Ichikawa S; Hirabayashi Y; Holleran WM; Okazaki T
Cancer Res; 2004 Sep; 64(17):6271-9. PubMed ID: 15342415
[TBL] [Abstract][Full Text] [Related]
9. Suppression of glucosylceramide synthase by RNA interference reverses multidrug resistance in human breast cancer cells.
Sun YL; Zhou GY; Li KN; Gao P; Zhang QH; Zhen JH; Bai YH; Zhang XF
Neoplasma; 2006; 53(1):1-8. PubMed ID: 16416005
[TBL] [Abstract][Full Text] [Related]
10. Constructing the eukaryotic expression vector to study preliminarily the functions of hammerhead ribozyme targeting base excision repair gene HOGG1.
Zhang ZZ; Zhang Q; Wu M
Sichuan Da Xue Xue Bao Yi Xue Ban; 2006 Mar; 37(2):165-70. PubMed ID: 16608066
[TBL] [Abstract][Full Text] [Related]
11. [siRNA-mediated silencing of ClC-2 gene inhibits proliferation of human U-87 glioma cells].
Yang XY; Lai XG; Zhang Y; Pei JM; Yang AG; Zhou SS
Ai Zheng; 2006 Jul; 25(7):805-10. PubMed ID: 16831268
[TBL] [Abstract][Full Text] [Related]
12. [Reversing multidrug resistance in breast cancer cell line MCF-7/ADR by small interfering RNA].
Li CB; Zhang F; Shi YR; Wei XY; Yang Y; Niu RF
Ai Zheng; 2004 Dec; 23(12):1605-10. PubMed ID: 15601546
[TBL] [Abstract][Full Text] [Related]
13. [Effect of silencing hypoxia-inducible factor-1 alpha by RNA interference on human breast carcinoma cell line].
Wang H; Liu YJ; Han ZB; Liang LH; Lv LL; Han ZC
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2006 Oct; 28(5):670-4. PubMed ID: 17121229
[TBL] [Abstract][Full Text] [Related]
14. [Inhibition of tissue factor by siRNA enhances doxorubicin-induced apoptosis in human neuroblastoma].
Fang J; Tang H; Xia LH; Zhou MX; Chen Y; Wei WN; Hu Y; Song SJ
Zhonghua Xue Ye Xue Za Zhi; 2007 Sep; 28(9):594-7. PubMed ID: 18246814
[TBL] [Abstract][Full Text] [Related]
15. [Status of estrogen receptor affects the drug sensitivity of drug-resistant MCF-7/Adr human breast cancer cells to droloxifene and Adriamycin].
Gao HD; Sun JZ; Bi DS; Ma R
Ai Zheng; 2003 Apr; 22(4):376-9. PubMed ID: 12703992
[TBL] [Abstract][Full Text] [Related]
16. [Construction of RNA interference expression vectors of human neuropathy target esterase and its inhibition for expression of NTE in mammalian cells].
Chang PA; Chen R; Li W; Wu YJ
Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2006 Jan; 24(1):27-30. PubMed ID: 16600090
[TBL] [Abstract][Full Text] [Related]
17. Molecular mechanisms of loss of beta 2-microglobulin expression in drug-resistant breast cancer sublines and its involvement in drug resistance.
Ogretmen B; McCauley MD; Safa AR
Biochemistry; 1998 Aug; 37(33):11679-91. PubMed ID: 9709006
[TBL] [Abstract][Full Text] [Related]
18. [Specific inhibition of HER-2 expression in ovarian carcinoma cells by siRNA targeting HER-2].
Lu YM; Zhang SL; Meng LR; Zhao YY
Zhonghua Yi Xue Za Zhi; 2006 Mar; 86(9):619-23. PubMed ID: 16681908
[TBL] [Abstract][Full Text] [Related]
19. [Screening the effective target sequences of laryngeal carcinoma related gene LCRG1].
Duan CJ; Jiang TB; Li C
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2008 Jun; 33(6):468-75. PubMed ID: 18599992
[TBL] [Abstract][Full Text] [Related]
20. Construction of survivin siRNA expression vector and its regulation on cell cycle and proliferation in MCF-7 cells.
Li LP; Liang NC; Luo CQ
Ai Zheng; 2004 Jul; 23(7):742-8. PubMed ID: 15248905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
